• Latest

Dr. Reddy’s Laboratories Limited through its wholly owned subsidiary, Dr. Reddy’s Laboratories SA, announces positive topline results from Phase 2b study of PPC-06 in patients with moderate to severe plaque psoriasis

Hyderabad,June 11, 2019: Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to…